Riskpilot← Back to searchSign inGet full accessLIENS OPTISKE AS
ASActiveOrg 933217523Rådmann Halmrasts Vei 2, 1337 SandvikaRetail sale of medical and orthopaedic goods · NACE 4774Est. 19818 employees
Revenue 2025
NOK 13,7M
-1% vs 2024
EBITDA margin
19.5%
+840% vs 2024
Equity ratio
10.4%
Financial strength
Net profit 2025
NOK 1,8M
+2890% vs 2024
| Revenue | NOK 13,7M | -1% |
| EBITDA | NOK 2,7M | +840% |
| Net profit | NOK 1,8M | +2890% |
| Total assets | NOK 5,3M | +28% |
| Equity | NOK 548K | +159% |
| Employees | 8 | — |
Legal name
LIENS OPTISKE AS
Org number
933217523
Legal form
Aksjeselskap
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
16. desember 1981
Share capital
—
Employees
8 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Address
Rådmann Halmrasts Vei 2, 1337 Sandvika
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 14 352 | 13 258 | 13 678 | 13 885 | 13 740 |
| Staff expenses | −4 389 | −4 606 | −4 870 | −5 521 | −4 800 |
| EBITDA | 3 954 | 2 980 | 2 736 | 286 | 2 685 |
| Depreciation & amort. | −50 | −168 | −158 | −272 | −265 |
| EBIT | 3 904 | 2 812 | 2 578 | 13 | 2 419 |
| Net financials | 15 | 22 | 35 | −35 | −74 |
| Profit before tax | 3 919 | 2 834 | 2 614 | −22 | 2 346 |
| Tax | 856 | 599 | 559 | −83 | 509 |
| Net profit | 3 063 | 2 234 | 2 055 | 61 | 1 837 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 6 093 | 4 831 | 4 732 | 4 140 | 5 279 |
| Equity | 160 | 151 | 150 | 211 | 548 |
| Long-term debt | 0 | 0 | 0 | 1 325 | 1 025 |
| Short-term debt | 5 933 | 4 681 | 4 582 | 2 603 | 3 706 |
| Total debt | 5 933 | 4 681 | 4 582 | 3 928 | 4 731 |
EBITDA margin
19.5%
This company
15.8%
Market median
+23% vs market
20212025
Equity ratio
10.4%
This company
38.2%
Market median
-73% vs market
20212025
Return on equity
335.0%
This company
18.4%
Market median
+1721% vs market
20212025
Net profit margin
13.4%
This company
8.1%
Market median
+65% vs market
20212025
Asset turnover
2.60×
This company
1.12×
Market median
+132% vs market
20212025
Debt / equity
8.63×
This company
0.62×
Market median
-1292% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HI Chief Executive Officer | Chief Executive Officer | 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2024 | |
| Former (2) | ||
| Board of Directors | 2017 – 2022 | |
| Chairman | 2022 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 54% | 54% | 2023 | |
| Company | 50% | 50% | 2024 | |
| Company | 50% | 50% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
H2m Holding As
LIENS OPTISKE AS Board members of LIENS OPTISKE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Håkon Ivar Muggerud | Chief Executive Officer | 0 companies |
| Vegard Bjørkelund Haugen | Chairman | 0 companies |
| Ragnar Lien | Board of Directors | 0 companies |
| Roar Kleven | Chairman | 0 companies |